Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 24, 2014 07:00 ET | Source: QLT Inc.

QLT Appoints Dr. Geoffrey F. Cox as Interim Chief Executive Officer

VANCOUVER, British Columbia, Oct. 24, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that current QLT Board member, Geoffrey F. Cox, Ph.D., has been...
October 09, 2014 06:47 ET | Source: QLT Inc.

QLT Announces Merger With Auxilium Pharmaceuticals, Inc. Terminates for Superior Proposal

VANCOUVER, British Columbia, Oct. 9, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by Auxilium Pharmaceuticals, Inc....
September 22, 2014 07:07 ET | Source: QLT Inc.

QLT Provides Further Update on Merger With Auxilium Pharmaceuticals, Inc.

VANCOUVER, British Columbia, Sept. 22, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by Auxilium Pharmaceuticals, Inc....
September 17, 2014 07:05 ET | Source: QLT Inc.

QLT Provides Update on Merger With Auxilium Pharmaceuticals, Inc.

VANCOUVER, British Columbia, Sept. 17, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by Auxilium Pharmaceuticals, Inc....
September 12, 2014 07:00 ET | Source: QLT Inc.

QLT Announces Positive Final Results From Phase 1b Retreatment Trial With Oral Synthetic cis-Retinoid (QLT091001) in Subjects With LCA or RP Due to Mutations in RPE65 or LRAT

VANCOUVER, B.C., Sept. 12, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced positive final results from its international, multi-center, Phase 1b...
August 07, 2014 07:00 ET | Source: QLT Inc.

QLT Announces Adoption of Advance Notice Policy

VANCOUVER, British Columbia, Aug. 7, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announces the approval by its board of directors of an advance notice policy...
August 05, 2014 07:00 ET | Source: QLT Inc.

QLT Announces Second Quarter 2014 Results

VANCOUVER, British Columbia, Aug. 5, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of...
July 14, 2014 07:00 ET | Source: QLT Inc.

QLT Announces Publication in The Lancet of Phase 1b Data for QLT091001 in Leber Congenital Amaurosis Due to LRAT or RPE65 Mutations

VANCOUVER, British Columbia, July 14, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced the publication of data from its Phase 1b proof-of-concept...
April 30, 2014 07:00 ET | Source: QLT Inc.

QLT Announces First Quarter 2014 Results

VANCOUVER, British Columbia, April 30, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and...
February 28, 2014 07:00 ET | Source: QLT Inc.

QLT Announces Fourth Quarter and Year End 2013 Results

VANCOUVER, British Columbia, Feb. 28, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization...